Editor's Pick
Pete presents the 100th and final edition of StockCharts TV‘s Halftime! This week, Pete shares some parting tips on what to look for when the trends...
Connect with us
Hi, what are you looking for?
HorizonLifeTime.com
- Investing
- Tech News
Here are the best iPad deals right now
iMessage had an outage, but now it’s back
Google’s Gemini AI plan for schools promises extra data protection and privacy
Newspaper conglomerate Gannett is adding AI-generated summaries to the top of its articles
OpenAI strikes Reddit deal to train its AI on your posts
- Stock
- Editor’s Pick
Editor's Pick
In this edition of StockCharts TV‘s The Final Bar, legendary trader and author Larry Williams joins Dave in the StockCharts TV studio. Larry shares his latest...
Editor's Pick
Today, the Biotechnology ETF (IBB) 20-day EMA crossed up through the 50-day EMA (Silver Cross), generating an IT Trend Model BUY Signal. If we...
Editor's Pick
Note to the reader: This is the twenty-first in a series of articles I’m publishing here taken from my book, “Investing with the Trend.”...
Editor's Pick
Travis Fisher Disclaimer: I served as a staff economist at the Federal Energy Regulatory Commission from 2006 to 2013 and as a commissioner adviser from 2018 to...
Editor's Pick
Feel like you never find those high-flying stocks before they make their big moves? This week’s edition of StockCharts TV‘s StockCharts in Focus is for you!...
Editor's Pick
Make absolutely no mistake about it, Friday was the most bearish day of 2024. There was a bearish engulfing candle on MASSIVE volume in...
Editor's Pick
NVIDIA (NVDA) was enjoying quite a rally to start the day. All seemed right with the world. Someone recently said to me, regarding another...
Editor's Pick
In this edition of StockCharts TV‘s The Final Bar, Grayson and Dave run through the 10 charts they feel present actionable opportunities based on their technical...
Editor's Pick
If you ran a StockCharts scan for Runaway Gaps (Runaway Gap Ups) on Thursday, you would have come across only 12 stocks. Among them,...
Editor's Pick
Clark Packard Last week, dozens of members of the House Republican Study Committee introduced the Countering Communist China Act (CCCA), which would, among other...
Editor's Pick
It is no secret that the NYFANG+ Index is still in in incredible up-run after bottoming out in October last year and subsequently breaking...
Editor's Pick
Jeffrey A. Singer The Food and Drug Administration will delay a decision to allow Eli Lilly and Company to market its new drug, donanemab. Clinical...
Editor's Pick
Colleen Hroncich Nikki Duslak says she never fit in as a public school teacher. “I have a background in theater—a bachelor’s degree in fine art and...
